COLUMN GROUP III GP, LP

Average Profitability
17.53%
Insider Buys Quantity
9
Insider Buys Sum
$67.56M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of COLUMN GROUP III GP, LP

According to the SEC Form 4 filings, COLUMN GROUP III GP, LP, being in a position of

  1. 10 percent owner at Surrozen, Inc.,
    оver the last 12 months, has bought 193548 shares for $3M, and sold 0 shares,
    over all time since 2024-04-04, has bought 193548 shares for $3M, and sold 0 shares.

The largest purchase of all time was on 2025-03-05 and amounted to 35714284 shares of Tenaya Therapeutics, Inc. for $25M.

Biography of COLUMN GROUP III GP, LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $27,999,9932100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-03-05PurchaseTenaya Therapeutics, Inc.
TNYA
10 percent owner
35.71M
63.7654%
$0.70$25M+25.36%
2024-04-04PurchaseSurrozen, Inc.
SRZN
10 percent owner
193,548
7.5667%
$15.50$3M-9.62%
2024-02-12PurchaseTenaya Therapeutics, Inc.
TNYA
10 percent owner
2.22M
2.6767%
$4.50$10M-47.35%
2023-03-10PurchaseTenaya Therapeutics, Inc.
TNYA
10 percent owner
6,779
0.0092%
$2.60$17,596+47.7%
2023-02-08PurchaseTenaya Therapeutics, Inc.
TNYA
10 percent owner
1.5M
1.9331%
$2.60$3.9M+16.3%
2023-01-19PurchaseTenaya Therapeutics, Inc.
TNYA
director
69,739
0.0935%
$2.50$174,201+24.31%
2023-01-18PurchaseTenaya Therapeutics, Inc.
TNYA
director
135,688
0.1854%
$2.52$341,432+25.4%
2023-01-17PurchaseTenaya Therapeutics, Inc.
TNYA
director
49,463
0.067%
$2.49$123,395+25%
2022-11-21PurchaseTenaya Therapeutics, Inc.
TNYA
director
9.62M
23.9374%
$2.60$25M+31.33%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.